Aeterna Zentaris
AEZS
#10198
Rank
HK$0.13 B
Marketcap
HK$44.53
Share price
2.14%
Change (1 day)
N/A
Change (1 year)

EPS for Aeterna Zentaris (AEZS)

EPS in 2024 (TTM): -HK$16.03

According to Aeterna Zentaris's latest financial reports the company's current EPS (TTM) is -HK$15.95. In 2022 the company made an earnings per share (EPS) of -HK$36.43 a decrease over its 2021 EPS that were of -HK$14.17.

EPS history for Aeterna Zentaris from 1998 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-HK$16.03
2022-HK$36.43157.14%
2021-HK$14.17-41.48%
2020-HK$24.21-64.46%
2019-HK$68.12-240%
2018HK$48.65-122.32%
2017-HK$217.97-53.53%
2016-HK$469.02-86.71%
2015-HK$3,530-35.21%
2014-HK$5,449-216.67%
2013HK$4,671-123.3%
2012-HK$20,045-40.8%
2011-HK$33,863-6.45%
2010-HK$36,198-27.91%
2009-HK$50,211-61.61%
2008-HK$130,78183.61%
2007-HK$71,229-195.31%
2006HK$74,732178.26%
2005HK$26,857-330%
2004-HK$11,677-80.05%
2003-HK$58,53017.78%
2002-HK$49,695515.93%
2001-HK$8,068-68.6%
2000-HK$25,698119.62%
1999-HK$11,701-3.63%
1998-HK$12,142

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Spectrum Pharmaceuticals
SPPI
-HK$2.80-82.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$57.29-459.22%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Bristol-Myers Squibb
BMY
HK$23.12-244.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$28.85-280.86%๐Ÿ‡ซ๐Ÿ‡ท France
Halozyme Therapeutics
HALO
HK$38.07-338.66%๐Ÿ‡บ๐Ÿ‡ธ USA